Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.779216
Title: Role of PI3K p110α in adrenergic regulation of adipose tissue metabolism
Author: Yan, Anqi
ISNI:       0000 0004 7964 916X
Awarding Body: UCL (University College London)
Current Institution: University College London (University of London)
Date of Award: 2019
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
The insulin signalling pathway plays a pivotal role in the regulation of cellular and organismal metabolism. The phosphoinositide 3-kinase (PI3K) catalytic subunit p110a is the principal PI3K catalytic subunit engaged in signalling downstream of insulin receptor (IR). Recent research has demonstrated that inhibition of PI3K has beneficial effects on adipose tissue metabolism and protects mice as well as primates from obesity and metabolic syndrome. Mice with global inactivation of the p110a subunit accumulate less body weight with age and have less fat tissue compared to wild type mice. Here we have investigated the effects of adipose tissue-specific p110a deletion on the metabolic physiology of mice over the course of ageing. We found that adipose tissue-specific inactivation of p110a conferred protection from age-related weight gain. At the molecular level, this was mediated by potentiation of beta-adrenergic receptor signalling, as a result of PI3K p110a inhibition, which impacted on cellular phosphodiesterase activity and cAMP levels. The beta-adrenergic receptor signalling pathway is well-known to regulate adipose tissue metabolism. The potentiating effect of p110a inhibition on adrenergic signalling was evident in young mice and middle- age mice, but not in very old mice. Inactivation of PI3K p110a potentiated beta- adrenergic signalling in subcutaneous, but not in visceral, white adipose tissue. Similar results were obtained in a cell line of adipocytes derived from mesenchymal stem cells isolated from human subcutaneous adipose tissue (hMADS). Moreover, pharmacologic inhibition of PI3K p110a promoted mitochondrial metabolism in adipocytes. Consistently, beta-adrenergic agonists increased lipolysis and expression of uncoupling protein 1 to a greater extent under conditions of p110a inhibition in the adipose tissue. Thus, p110a inactivation promoted a so-called 'browning' effect in white adipose tissue which increased fatty acid catabolism and energy dissipation as heat. This might be producing a beneficial metabolic effect by preventing lipotoxicity induced by fatty acid accumulation. This in turn might be protecting the adipose tissue from fatty acid-induced senescence.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.779216  DOI: Not available
Share: